Paper · 23643243
One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering.
Wang H and 6 others. Cell, 2013. Cited by 2,744 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Papers, record 23643243. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23643243
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Gene Targeting | Major topic |
| Mice | Major topic |
| Animals | |
| Base Sequence | |
| Embryonic Stem Cells | |
| Female | |
| Male | |
| Mice, Inbred C57BL | |
| Mice, Inbred DBA | |
| Molecular Sequence Data | |
| RNA, Small Untranslated |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01-CA084198 | NCI NIH HHS | United States | R01CA084198 | PubMed and NIH | NIH RePORTER |
| R37 HD045022 | NICHD NIH HHS | United States | R37HD045022 | PubMed and NIH | NIH RePORTER |
| DP1 MH100706 | NIMH NIH HHS | United States | DP1MH100706 | PubMed and NIH | NIH RePORTER |
| R01 CA084198 | NCI NIH HHS | United States | R01CA084198 | PubMed and NIH | NIH RePORTER |
| R37-HD045022 | NICHD NIH HHS | United States | R37HD045022 | PubMed and NIH | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23,302,927 | Knockout mice created by TALEN-mediated gene targeting. | Nat Biotechnol | 2013 | https://conductscience.org/library/papers/23302927 | PubMed |
| 2 | 23,360,964 | Efficient genome editing in zebrafish using a CRISPR-Cas system. | Nat Biotechnol | 2013 | https://conductscience.org/library/papers/23360964 | PubMed |
| 3 | 21,892,189 | The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. | Nature | 2011 | https://conductscience.org/library/papers/21892189 | PubMed |
| 4 | 21,910,633 | Double-strand break end resection and repair pathway choice. | Annu Rev Genet | 2011 | https://conductscience.org/library/papers/21910633 | PubMed |
| 5 | 23,360,965 | RNA-guided editing of bacterial genomes using CRISPR-Cas systems. | Nat Biotechnol | 2013 | https://conductscience.org/library/papers/23360965 | PubMed |
| 6 | 23,426,636 | Direct production of mouse disease models by embryo microinjection of TALENs and oligodeoxynucleotides. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/23426636 | PubMed |
| 7 | 21,803,851 | Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. | Blood | 2011 | https://conductscience.org/library/papers/21803851 | PubMed |
| 8 | 21,757,228 | Generation of isogenic pluripotent stem cells differing exclusively at two early onset Parkinson point mutations. | Cell | 2011 | https://conductscience.org/library/papers/21757228 | PubMed |
| 9 | 23,352,810 | Combined deficiency of Tet1 and Tet2 causes epigenetic abnormalities but is compatible with postnatal development. | Dev Cell | 2013 | https://conductscience.org/library/papers/23352810 | PubMed |
| 10 | 21,960,622 | TAL effectors: customizable proteins for DNA targeting. | Science | 2011 | https://conductscience.org/library/papers/21960622 | PubMed |
1 to 10 of 34
See all 34 referencesCited by1,975
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2,744 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,988,810 | Consecutive waves of NODAL inhibition are required for epiblast patterning. | Nat Commun | 2026 | https://conductscience.org/library/papers/42988810 | PubMed |
| 42,909,932 | Recent advances in CRISPR technologies for biomedical applications and disease treatment. | Theranostics | 2026 | https://conductscience.org/library/papers/42909932 | PubMed |
| 42,891,351 | Strategies and mechanisms of precision genome engineering: From gene editing to genome writing. | IMetaOmics | 2026 | https://conductscience.org/library/papers/42891351 | PubMed |
| 42,728,430 | Structural evolution of ionizable lipids for nucleic acid delivery. | Nat Rev Chem | 2026 | https://conductscience.org/library/papers/42728430 | PubMed |
| 42,627,856 | Caveolin 1 is a conserved host factor mediating Bacillus cereus hemolysin BL toxin cytolytic toxicity. | PLoS Biol | 2026 | https://conductscience.org/library/papers/42627856 | PubMed |
| 42,584,780 | Generation and Validation of an Acan-Cre Mouse Line to Selectively Label Class-B Excitatory Neurons of the Cerebellar Nuclei. | Cerebellum | 2026 | https://conductscience.org/library/papers/42584780 | PubMed |
| 42,578,365 | Specific cleavage of 5' overhangs of non-target strand by Cas9 activated by target DNA binding. | Nucleic Acids Res | 2026 | https://conductscience.org/library/papers/42578365 | PubMed |
| 42,391,007 | Overcoming the challenges of genome-editing essential genes. | STAR Protoc | 2026 | https://conductscience.org/library/papers/42391007 | PubMed |
| 42,363,245 | A streamlined approach for gene editing in non-obese diabetes (NOD) mice via CRISPR/Cas9. | Lab Anim Res | 2026 | https://conductscience.org/library/papers/42363245 | PubMed |
| 42,315,520 | Deep learning-guided engineering of SpuFz1 and rational miniaturization of ωRNA enables efficient genome editing. | Nat Commun | 2026 | https://conductscience.org/library/papers/42315520 | PubMed |
1 to 10 of 1,975
See all 1,975 cited byGenes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TET2 | 54,790 | PubTator's text mining | https://conductscience.org/library/genes/54790 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23643243
GET https://conductscience.org/api/papers/v1/23643243/references?page=2